Inclusion of Strep-Tag II in design of antigen receptors for T cell immunotherapy

por Liu, Lingfeng, Sommermeyer, Daniel, Cabanov, Alexandra, Kosasih, Paula, Hill, Tyler, Riddell, Stanley R
Publicado 2016

Safety of targeting ROR1 for cancer immunotherapy with chimeric antigen receptor-modified T cells in a primate model

por Berger, S Carolina, Sommermeyer, Daniel, Hudecek, Michael, Berger, Michael, Balakrishnan, Ashwini, Paskiewicz, Paulina, Kosasih, Paula, Rader, Christoph, Riddell, Stanley
Publicado 2014

Chimeric antigen receptor-modified T cells derived from defined CD8(+) and CD4(+) subsets confer superior antitumor reactivity in vivo

por Sommermeyer, Daniel, Hudecek, Michael, Kosasih, Paula L., Gogishvili, Tea, Maloney, David G., Turtle, Cameron J., Riddell, Stanley R.
Publicado 2015